Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingemar S J Merkies

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Neurology|April 10, 2013
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trialIngemar S J Merkies
Developmental Medicine and Child Neurology|December 3, 2022
Proceed with caution: Benefits and drawbacks of modern clinimetric analysisTatiana Hamadeh, Ingemar S J Merkies
European Neurology|April 15, 2016
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating PolyradiculoneuropathyIngemar S J Merkies, Bernd C Kieseier
Neuromuscular Disorders : NMD|November 28, 2012
Fatigue in immune-mediated neuropathiesIngemar S J Merkies, Catharina G Faber
Neuroscience Letters|March 1, 2015
Peripheral neuropathies: Moving closer to mechanismCatharina G Faber, Ingemar S J Merkies
Neuromuscular Disorders : NMD|June 2, 2009
Outcome measures in Duchenne muscular dystrophy: are we ready for the new therapeutic era?Ingemar S J Merkies, Catharina G Faber
Current Opinion in Neurology|September 5, 2008
How to assess new drugs for neuropathies: advances in trial design and methodologyPieter A van Doorn, Ingemar S J Merkies
Current Opinion in Neurology|September 4, 2012
Outcome measures in peripheral neuropathies: requirements through statementsIngemar S J Merkies, Giuseppe Lauria, Catharina G Faber
Neuroscience Letters|February 24, 2015
Advances in diagnostics and outcome measures in peripheral neuropathiesIngemar S J Merkies, Catharina G Faber, Giuseppe Lauria
Current Opinion in Neurology|September 4, 2012
Small fibre neuropathyGiuseppe Lauria, Ingemar S J Merkies, Catharina G Faber
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Neurology|April 10, 2013
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trialIngemar S J Merkies
Developmental Medicine and Child Neurology|December 3, 2022
Proceed with caution: Benefits and drawbacks of modern clinimetric analysisTatiana Hamadeh, Ingemar S J Merkies
European Neurology|April 15, 2016
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating PolyradiculoneuropathyIngemar S J Merkies, Bernd C Kieseier
Neuromuscular Disorders : NMD|November 28, 2012
Fatigue in immune-mediated neuropathiesIngemar S J Merkies, Catharina G Faber
Neuroscience Letters|March 1, 2015
Peripheral neuropathies: Moving closer to mechanismCatharina G Faber, Ingemar S J Merkies
Neuromuscular Disorders : NMD|June 2, 2009
Outcome measures in Duchenne muscular dystrophy: are we ready for the new therapeutic era?Ingemar S J Merkies, Catharina G Faber
Current Opinion in Neurology|September 5, 2008
How to assess new drugs for neuropathies: advances in trial design and methodologyPieter A van Doorn, Ingemar S J Merkies
Current Opinion in Neurology|September 4, 2012
Outcome measures in peripheral neuropathies: requirements through statementsIngemar S J Merkies, Giuseppe Lauria, Catharina G Faber
Neuroscience Letters|February 24, 2015
Advances in diagnostics and outcome measures in peripheral neuropathiesIngemar S J Merkies, Catharina G Faber, Giuseppe Lauria
Current Opinion in Neurology|September 4, 2012
Small fibre neuropathyGiuseppe Lauria, Ingemar S J Merkies, Catharina G Faber
Pageof 15